This digital collection is dedicated to innovation in pharma and biotech — exploring how AI, digital tools, and new ways of collaborating are fundamentally changing how drugs are discovered, developed, and brought to market. From breakthrough approaches in biomanufacturing to bold partnerships between pharma and biotech, the collection showcases the ideas and technologies driving the industry forward.This digital collection is dedicated to innovation in pharma and biotech — exploring how AI, digital tools, and new ways of collaborating are fundamentally changing how drugs are discovered, developed, and brought to market. From breakthrough approaches in biomanufacturing to bold partnerships between pharma and biotech, the collection showcases the ideas and technologies driving the industry forward.
Key Topics Covered
- Beyond Open InnovationHow to Make Pharma–Biotech Collab Work at ScaleInterview with Ruth Shah, Head of Berlin Co.Lab, Bayer
- AI as a Game-ChangerHow Artificial Intelligence Is Transforming the Work of Biotech and Pharmaceutical CompaniesThorsten Schüller, CHEManager
- Trusted Evidence in the Age of AIIntegrating Peer-reviewed Content into Clinical WorkflowsJosh Jarrett, SVP of AI Growth, Wiley
- The Hidden Cost of How Chemical Companies ExperimentSmart Experimentation is the Most Important Productivity Lever for R&D OrganizationsFlorian Vogt, Senior Systems Engineer, JMP
- Digital Innovation Needs the Right MindsetCloud, AI & Quantum Computing: Boehringer Ingelheim's Digital StrategyInterview with Clemens Utschig-Utschig, Head of IT Technology Strategy / CTO, Boehringer Ingelheim
Read issue
Download PDF
